Dinoprostone Vaginal Insert Versus Double Balloon Catheter for Preinduction Cervical Ripening
Launched by KANUNI SULTAN SULEYMAN TRAINING AND RESEARCH HOSPITAL · Jan 9, 2017
Trial Information
Current as of June 01, 2025
Unknown status
Keywords
ClinConnect Summary
The study will be conducted in the Department of Obstetrics and Gynecology at Kanuni Sultan Süleyman Education and Research Hospital ,İstanbul, Turkey, with approval of the local institutional review board. All the participants will give informed consent before beginning of the study. Women who agree to participate will be first stratified into nulliparous and multiparous groups. Randomisation will be carried out by using sealed opaque envelopes with a piece of paper inside marked 'PGE2 vaginal insert' or 'Double-balloon catheter'. Envelopes will be prepared in blocks of 20 (10 PGE2 vaginal...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Eligible women have obstetric or medical indications for labor induction with intact membranes
- • singleton pregnancies,
- • vertex presentations
- • low Bishop scores ≤6
- • gestational age ≥34 w
- • reassuring fetal heart tracing on admission.
- Exclusion Criteria:
- • Exclusion criteria are placenta previa
- • unexplained vaginal bleeding
- • nonvertex presentation
- • intrauterine fetal death
- • prior cesarean delivery
- • any scarred uterus
- • any other contraindications for vaginal delivery.
About Kanuni Sultan Suleyman Training And Research Hospital
Kanuni Sultan Suleyman Training and Research Hospital is a prominent healthcare institution dedicated to advancing medical knowledge and improving patient care through rigorous clinical research. As a leading sponsor of clinical trials, the hospital fosters innovation by collaborating with multidisciplinary teams of healthcare professionals and researchers to investigate new treatment modalities and therapeutic options. Committed to ethical standards and patient safety, the hospital plays a vital role in translating research findings into clinical practice, thereby contributing to the enhancement of health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials